Ethosuximide Should Not Be Used for Focal (Partial) Seizures
Ethosuximide is contraindicated as monotherapy for focal seizures because it has no efficacy against this seizure type and may even worsen generalized tonic-clonic seizures if they coexist. 1, 2
Why Ethosuximide is Inappropriate for Focal Seizures
Narrow Spectrum of Activity
- Ethosuximide has a narrow therapeutic profile limited exclusively to absence (petit mal) seizures 2
- The drug works by reducing low-threshold T-type calcium currents in thalamic neurons, a mechanism specific to the thalamocortical circuitry that generates absence seizures 2
- Ethosuximide is probably inefficacious on tonic-clonic seizures and has no documented activity against focal seizures 1
Evidence-Based First-Line Options for Focal Seizures
For newly diagnosed focal (partial) seizures, the appropriate first-line monotherapy options are:
Children and Adults:
- Carbamazepine (ILAE level A-C for adults, Cochrane strong evidence for children) 3
- Lamotrigine (ILAE level A-C for adults, Cochrane strong evidence for children) 3
- Levetiracetam (ILAE level A-C for adults, Cochrane strong evidence for children) 3
Additional Options:
- Oxcarbazepine for children (level A evidence, though based on single class I trial) 3, 4
- Eslicarbazepine acetate, lacosamide, or zonisamide for adults (ILAE level A) 3
- Gabapentin specifically for elderly patients (ILAE level A) 3
Clinical Pitfall to Avoid
The most critical error would be prescribing ethosuximide to a patient with focal seizures under the mistaken belief that it has broad-spectrum antiepileptic activity. If a patient has both absence seizures AND focal seizures, valproate should be chosen instead of ethosuximide because ethosuximide will not control the focal component 1
When Ethosuximide IS Appropriate
Ethosuximide remains the drug of choice only for childhood absence epilepsy without generalized tonic-clonic seizures (ILAE level A evidence), where it demonstrates superior effectiveness and tolerability compared to lamotrigine 1, 3